TABLE 1.
MIC (μg/mL) |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Antibiotic at the indicated MIC breakpoints (μg/mL) (S–R)b |
||||||||||
ATM | CAZ | FEP | IPM | CIP | LVX | GEN | TOB | COL | ||
Straina | 8–32 | 8–32 | 8–32 | 2–8 | 0.5–2 | 1–4 | 4–16 | 4–16 | 2–4 | FFA |
QC | ||||||||||
ATCC 25922 | 0.06 | 0.12 | 0.016 | 0.06 | 0.008 | 0.008 | 0.5 | 1 | 1 | |
ATCC 27853 | 4 | 1 | 2 | 1 | 0.25 | 0.5 | 1 | 1 | 1 | |
P. aeruginosa | ||||||||||
TL1671 | 8 | 4 | 8 | 2 | 0.25 | 1 | 2 | 1 | 32 | >512 |
TL1736 | 4 | 4 | 2 | 16 | 1 | 1 | 32 | 8 | 8 | >512 |
TL1744 | 32 | 32 | 16 | 16 | 32 | 8 | ≥128 | 32 | 4 | >512 |
TL2314 | 16 | 32 | 16 | 4 | 0.5 | 2 | 8 | 2 | 8 | >512 |
TL2917 | 32 | 16 | 16 | 16 | 0.25 | 2 | 8 | 8 | 8 | >512 |
TL2967 | 128 | 16 | 32 | 16 | 8 | 16 | 8 | 8 | 4 | >512 |
TL3008 | 4 | 2 | 4 | 16 | 0.5 | 1 | 16 | 4 | 32 | >512 |
TL3086 | 128 | 16 | 16 | ≥128 | 16 | 8 | ≥128 | 128 | 32 | >512 |
4–16 | 4–16 | 2–16 | 1–4 | 0.25–1 | 0.5–2 | 4–16 | 4–16 | 2–4 | ||
E. coli | ||||||||||
DC90 | ≥256 | 32 | 64 | ≥256 | 64 | 32 | ≥256 | 128 | 8 | >512 |
DC3539 | 64 | 128 | ≥128 | 0.5 | 64 | 16 | 128 | 128 | 8 | >512 |
DC3599 | 64 | 16 | 8 | 1 | 4 | 8 | 16 | 8 | 8 | >512 |
DC3806 | 64 | 64 | 16 | 1 | 4 | 8 | 16 | 16 | 8 | >512 |
DC3846 | 128 | 64 | ≥256 | 0.5 | ≥256 | 128 | ≥256 | 64 | 8 | >512 |
DC4887 | 1 | 4 | 32 | 1 | 4 | 16 | 16 | 8 | 8 | >512 |
DC5286 | ≥256 | 128 | ≥256 | 0.25 | 128 | 64 | 4 | 4 | 8 | >512 |
DC7333 | ≥256 | ≥256 | ≥256 | 16 | ≥256 | 128 | 128 | ≥256 | 4 | >512 |
K. pneumoniae | ||||||||||
FK169 | ≥128 | 32 | 32 | 0.25 | 32 | 16 | 2 | 2 | 8 | >512 |
FK1342 | ≥128 | ≥128 | ≥128 | 0.25 | 1 | 0.5 | 1 | 4 | ≥128 | >512 |
FK1913 | ≥128 | ≥128 | ≥128 | 32 | ≥128 | 128 | ≥128 | ≥128 | 64 | >512 |
FK1986 | 0.0125 | 0.25 | 0.0125 | 0.25 | 0.0125 | 0.025 | 2 | 1 | 8 | >512 |
FK3810 | 0.0125 | 128 | ≥256 | 32 | ≥256 | 128 | ≥256 | ≥256 | 64 | >512 |
FK3994 | ≥256 | 128 | ≥256 | 32 | ≥256 | 64 | ≥256 | ≥256 | 64 | >512 |
FK6556 | 64 | 64 | 64 | 16 | 4 | 8 | 16 | 16 | 32 | >512 |
FK6663 | ≥256 | ≥256 | ≥256 | 32 | ≥256 | ≥256 | ≥256 | ≥256 | 16 | >512 |
— | 8–32 | 8–32 | 2–8 | 1–4 | 2–8 | 4–16 | 4–16 | 2–4 | ||
A. baumannii | ||||||||||
BM1539 | 16 | 8 | 64 | 16 | 4 | 2 | 1 | 1 | 16 | >512 |
BM1595 | 2 | 32 | 8 | 4 | 64 | 8 | 128 | 128 | 4 | >512 |
BM2349 | 16 | 64 | 64 | 16 | 4 | 8 | 1 | 1 | 4 | >512 |
BM2370 | 8 | 32 | 128 | 8 | 128 | 8 | 4 | 1 | 8 | >512 |
BM2412 | 16 | 64 | 64 | 16 | 4 | 8 | 4 | 1 | 16 | >512 |
BM2431 | 64 | 64 | 64 | 16 | 4 | 8 | 1 | 1 | 32 | >512 |
BM2622 | 64 | 64 | 64 | 8 | 4 | 8 | 16 | 16 | 4 | >512 |
Strains in boldface type are multidrug-resistant (MDR) strains.
Values in boldface type indicate resistance. S–R represents the susceptible (S) breakpoint to the resistant (R) breakpoint, according to CLSI supplement M100 (34) and EUCAST (49).
QC, quality control; ATM, aztreonam; CAZ, ceftazidime; FEP, cefepime; IMP, imipenem; CIP, ciprofloxacin; LVX, levofloxacin; GEN, gentamicin; TOB, tobramycin, COL, colistin; FFA, flufenamic acid.